378 related articles for article (PubMed ID: 17350721)
1. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.
Teixeira PJ; Seligman R; Hertz FT; Cruz DB; Fachel JM
J Hosp Infect; 2007 Apr; 65(4):361-7. PubMed ID: 17350721
[TBL] [Abstract][Full Text] [Related]
2. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
3. Incidence and risk factors for the development of acute renal failure in patients with ventilator-associated pneumonia.
Gursel G; Demir N
Nephrology (Carlton); 2006 Jun; 11(3):159-64. PubMed ID: 16756626
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors for ventilator-associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece.
Apostolopoulou E; Bakakos P; Katostaras T; Gregorakos L
Respir Care; 2003 Jul; 48(7):681-8. PubMed ID: 12841859
[TBL] [Abstract][Full Text] [Related]
6. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy.
Gursel G; Aydogdu M; Ozyilmaz E; Ozis TN
J Crit Care; 2008 Mar; 23(1):34-40. PubMed ID: 18359419
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical cure rates in adults with ventilator-associated pneumonia treated with intravenous ceftazidime administered by continuous or intermittent infusion: a retrospective, nonrandomized, open-label, historical chart review.
Lorente L; Jiménez A; Palmero S; Jiménez JJ; Iribarren JL; Santana M; Martín MM; Mora ML
Clin Ther; 2007 Nov; 29(11):2433-9. PubMed ID: 18158083
[TBL] [Abstract][Full Text] [Related]
9. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
Eachempati SR; Hydo LJ; Shou J; Barie PS
J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
[TBL] [Abstract][Full Text] [Related]
10. Impact of intensive-care-unit(ICU)-acquired ventilator-associated pneumonia(VAP) on hospital mortality: a matched-paired case-control study.
Uno H; Takezawa J; Yatsuya H; Suka M; Yoshida K
Nagoya J Med Sci; 2007 Jan; 69(1-2):29-36. PubMed ID: 17378178
[TBL] [Abstract][Full Text] [Related]
11. Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes.
Parker CM; Kutsogiannis J; Muscedere J; Cook D; Dodek P; Day AG; Heyland DK;
J Crit Care; 2008 Mar; 23(1):18-26. PubMed ID: 18359417
[TBL] [Abstract][Full Text] [Related]
12. Late-onset ventilator-associated pneumonia in nontrauma intensive care unit patients.
Gacouin A; Barbarot N; Camus C; Salomon S; Isslame S; Marque S; Lavoué S; Donnio PY; Thomas R; Le Tulzo Y
Anesth Analg; 2009 Nov; 109(5):1584-90. PubMed ID: 19713267
[TBL] [Abstract][Full Text] [Related]
13. Reduction in inadequate empiric antibiotic therapy for ventilator-associated pneumonia: impact of a unit-specific treatment pathway.
Magnotti LJ; Schroeppel TJ; Fabian TC; Clement LP; Swanson JM; Fischer PE; Bee TK; Maish GO; Minard G; Zarzaur BL; Croce MA
Am Surg; 2008 Jun; 74(6):516-22; discussion 522-3. PubMed ID: 18556994
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for relapse of ventilator-associated pneumonia in trauma patients.
Rangel EL; Butler KL; Johannigman JA; Tsuei BJ; Solomkin JS
J Trauma; 2009 Jul; 67(1):91-5; discussion 95-6. PubMed ID: 19590315
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia.
Agbaht K; Diaz E; Muñoz E; Lisboa T; Gomez F; Depuydt PO; Blot SI; Rello J
Crit Care Med; 2007 Sep; 35(9):2064-70. PubMed ID: 17581489
[TBL] [Abstract][Full Text] [Related]
16. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
[TBL] [Abstract][Full Text] [Related]
17. Infections in a surgical intensive care unit of a university hospital in Greece.
Markogiannakis H; Pachylaki N; Samara E; Kalderi M; Minettou M; Toutouza M; Toutouzas KG; Theodorou D; Katsaragakis S
Int J Infect Dis; 2009 Mar; 13(2):145-53. PubMed ID: 18775663
[TBL] [Abstract][Full Text] [Related]
18. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
Eagye KJ; Nicolau DP; Kuti JL
Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
[TBL] [Abstract][Full Text] [Related]
19. Ventilator-associated pneumonia in surgical emergency intensive care unit.
Ertugrul BM; Yildirim A; Ay P; Oncu S; Cagatay A; Cakar N; Ertekin C; Ozsut H; Eraksoy H; Calangu S
Saudi Med J; 2006 Jan; 27(1):52-7. PubMed ID: 16432594
[TBL] [Abstract][Full Text] [Related]
20. Incidence, risk factors, and outcome of ventilator-associated pneumonia.
Tejerina E; Frutos-Vivar F; Restrepo MI; Anzueto A; Abroug F; Palizas F; González M; D'Empaire G; Apezteguía C; Esteban A;
J Crit Care; 2006 Mar; 21(1):56-65. PubMed ID: 16616625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]